Blanket Purchase Agreement W81K0020A0015

Award Date 10/1/20
Last Date to Order 9/30/25
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency Contracting Activity (DHACA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, to procure various radiopharmaceuticals for use in the Nuclear Medicine Division at Naval Medical Center San Diego (NMCSD). The single-award, firm-fixed-price BPA is valued at $1,900,000.00 and has a performance period from October 1, 2024 to September 30, 2029. The BPA covers the acquisition of 31 different...
The Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Pharmalucence, Inc. as a single-award contract with a potential value of $1,250,000. The BPA aims to procure radiopharmaceutical supplies for Tripler Army Medical Center in Hawaii over a five-year period of performance from May 2021 through April 2026. Under the BPA, Pharmalucence will provide a range of radiopharmaceutical products to support nuclear medicine diagnostic imaging and related clinical...
This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Medi-Physics, Inc. to provide radiopharmaceutical supplies to Tripler Army Medical Center in Hawaii. The single award BPA has a potential value of $1.25 million and a period of performance through April 2026. The BPA facilitates orders for radiopharmaceutical supplies needed to support nuclear medicine diagnostic imaging services at Tripler Army Medical Center. As the primary provider of healthcare to...
The Blanket Purchase Agreement awarded by the Department of the Army Medical Command to Cardinal Health 414, LLC establishes a vehicle for procuring radiopharmaceutical supplies to support medical operations at Tripler Army Medical Center in Hawaii. The potential value of the BPA is $1,250,000 with a period of performance through April 2026. Four calls have been placed against the Defense Health Agency's BPAs for nuclear and radiopharmaceutical products. Cardinal Health 414, LLC was awarded...
The Blanket Purchase Agreement was awarded as a single award by the Department of the Army Medical Command to Med-Share Inc. to provide radiology services. With a potential value of $37,050, the BPA enables ordering activities within the agency to procure such services on an as-needed basis through January 13, 2026. The BPA facilitates the delivery of radiology services to various Department of the Army Medical Command facilities. As the prime contractor, Med-Share Inc. will utilize its...
The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Sr-Services GMBH on April 1, 2023. The BPA has a potential value of $725,000 and expires on April 23, 2028. It was not subject to any set-aside requirements. The BPA aims to procure radiopharmaceuticals for use in nuclear medical services. Sr-Services GMBH will supply these products to support the Defense Health Agency's mission of providing health care services to U.S. military service members, military families,...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Advanced Accelerator Applications USA Inc., a large, foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $23.4 million single-award BPA is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of February 3, 2025. The BPA is for the procurement of LOCAMETZ and NETSPOT, two...
This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Pharmarx Hawaii LLC on May 1, 2021. The potential value of the contract is $1,250,000. Orders may be placed through April 30, 2026 to procure radiopharmaceutical supplies in support of Tripler Army Medical Center in Hawaii. The contract aims to provide a wide range of medical isotopes and radiopharmaceuticals used in nuclear medicine imaging and therapeutic procedures. Common radiotracers such as...
The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Sun Pharmaceutical Industries, Inc. with a potential value of $8 million. The BPA is for the delivery of radiopharmaceutical dose products and consumables to support nuclear medicine services through January 2025. No set-asides were applied to this procurement. The original solicitation sought a contractor to provide radiopharmaceuticals and related supplies necessary for diagnostic imaging and therapeutic...
This Blanket Purchase Agreement (BPA) contract was awarded by the Defense Health Agency (DHA), a defense agency, to Curium US LLC, a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $8 million single-award BPA, along with a separate $1 million BPA, facilitate the streamlined procurement of radiopharmaceuticals and related services to support healthcare operations across military treatment facilities and meet the radiopharmaceutical requirements...

This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Alamo Nuclear Pharmacy Services Inc. on October 1, 2020, with a potential value of $400,000. The BPA provides for the delivery of radiopharmaceuticals to Army medical treatment facilities through September 30, 2025.

The originating sole source solicitation sought to procure stem cell transplant services for an urgent patient need at Brooke Army Medical Center. As the Regional Health Contracting Office-Central intended to make a noncompetitive award to National Marrow Donor Program, this notice was informational only and did not solicit competitive quotes. The scope of this BPA aligns with the Department of the Army Medical Command's mission to provide quality healthcare to soldiers and their families. By establishing this vehicle for radiopharmaceutical procurement, the agency can fulfill treatment requirements for nuclear medicine services across its military treatment network in a streamlined manner over the five-year period of performance.

Generated 1/4/24, 6:46 PM